Jun Jin Jiahao Du Yanwei Wu
10.1097/MD.0000000000013491
Medicine (Baltimore)
2019 Jan;98(1):e13491.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/30608382/
Antineoplastic Agents / therapeutic use Nasopharyngeal Carcinoma / drug therapy Nasopharyngeal Neoplasms / drug therapy Pyridines / therapeutic use
Antineoplastic Agents / therapeutic use Nasopharyngeal Carcinoma / drug therapy Nasopharyngeal Neoplasms / drug therapy Pyridines / therapeutic use Case Reports Humans Male Middle Aged Treatment Outcome Vascular Endothelial Growth Factor Receptor-2 / analysis Antineoplastic Agents Pyridines apatinib KDR protein, human Vascular Endothelial Growth Factor Receptor-2
PMC6344178
30608382
Apatinib monotherapy for advanced VEGFR-2-negative nasopharyngeal carcinoma: A case report
2019